Media Contact: Melody Udell
Join 4,000+ managed care pharmacy professionals at AMCP 2026 in Nashville, TN, April 13-16. Explore cutting-edge education, earn CE credits, and dive into Al, real-world evidence, precision medicine and other emerging health care trends. Network with leaders from health plans, PBMs, pharma, and more.
Each year, Asembia’s Specialty Pharmacy Summit is at the epicenter of the pharmacy industry, providing a unique opportunity for stakeholders throughout the industry to understand challenges, generate solutions and define the future. Asembia’s AXS26 Summit will return to the Wynn & Encore Las Vegas April 26-30, 2026.
The ASCO Annual Meeting is more than a conference—it’s the place to be a part of something bigger. This is where groundbreaking science, innovation, and connection come together to shape the future of cancer care.
AMCP Nexus attracts more than 2,500 managed care decision-makers each fall. Attendees include individuals from health plans, PBMs, biopharmaceutical companies, consultants, and other leaders working within managed care pharmacy.
The success of the TrumpRx platform depends in large part on pharmacies’ willingness to accept lower reimbursement rates for drugs they’ve already purchased. MMIT’s Steve Callahan explained that as the program grows, pharmacies might reconsider their business model to ensure they can meet their own margins.
In an effort to reduce healthcare costs, the FDA would like many prescription medications to become over-the-counter products. MMIT’s Steve Callahan explains that while this move would theoretically improve patient access, patients would be responsible for the full cost of these treatments.
A popular asthma medication, Xolair, was selected in the third cycle of the MDPNP—despite the fact that a competing biosimilar will launch before the negotiation period ends. Bloomberg Law taps MMIT’s Steve Callahan for his insights on the drug selection process and the biosimilar pipeline.
